tirzepatide alzheimer's A novel therapeutic prospect: a dual-acting for disease GLP-1s and Alzheimer's: What You

the placebo group (4.6% vs

The SEARCH for Diabetes in Youth study revealed an annual increase of 4.8% in the incidence of T2D among U.S

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Adderall: A Benchmark in ADHD and Narcolepsy Treatment Adderalls efficacy in treating ADHD symptoms is well-documented

Seek urgent medical attention (call 999 or go to A&E) if you experience: Severe or persistent vomiting, or inability to keep fluids down for more than 24 hours Severe upper abdominal pain, particularly if it radiates to the back (possible pancreatitis) Severe right-sided upper abdominal pain, with or without fever or yellowing of the skin or eyes (possible gallbladder problems a recognised class signal with GLP-1 receptor agonists) [14] [15] Contact NHS 111 or your GP if you experience: Fast, irregular heartbeat or palpitations Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking insulin or other glucose-lowering medicines Dizziness or signs of dehydration (reduced urine output, dry mouth, light-headedness) If you think you have experienced a side effect from any medicine, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app